BSE: STAR - Strides Pharma Science Limited

Rentabilité sur six mois: -33.73%

Calendrier des promotions Strides Pharma Science Limited

Calendrier avancé Graphique simple
Financial Markets by TradingView

À propos de l'entreprise

Strides Pharma Science Limited develops, manufactures, and sells pharmaceutical products in Africa, Australia, North America, Europe, Asia, India, and internationally. It operates through two segments, Pharmaceutical and Biopharmaceutical. The company offers pharma generics in various forms, such as tablets, hard and soft gelatin capsules, sachets, and liquids, as well as nasal spray, gels, powders, solids, ointments, and creams.

plus de détails
It also develops branded generics products for the treatment of chronic therapies, including women's health, central nervous system, cardiovascular, diabetes, dermatology, and probiotics under the Renerve, Unibrol, Combiart, Duotab, and Vitafer brands; and anti-retroviral, anti-malarial, anti-tuberculosis, Hepatitis, and other infectious disease drug segments for institutional business. The company was formerly known as Strides Shasun Limited and changed its name to Strides Pharma Science Limited in July 2018. Strides Pharma Science Limited was incorporated in 1990 and is headquartered in Bengaluru, India.
Ajouter à la liste de comparaison
Ajouter à la liste de surveillance
Ajouter au portefeuille
Ajouter un avis de prix

ISIN INE939A01011
Industry Pharmaceuticals
Sector Health Care
Валюта inr
Валюта отчета inr
Див.доход ао 0.0512
Дивиденд ао 1.14
Сайт https://www.strides.com
Цена ао 619.05
Changement de prix par jour: +0.9531% (619.05)
Changement de prix par semaine: -8.51% (683.05)
Changement de prix par mois: -12.81% (716.8)
Changement de prix sur 3 mois: -60.08% (1565.65)
Changement de prix sur six mois: -33.73% (943.05)
Changement de prix par an: -8.51% (683.1)
Evolution du prix sur 3 ans: +39.5% (448)
Evolution du prix sur 5 ans: +62.41% (384.8)
Evolution des prix sur 10 ans: 0% (624.95)
Evolution des prix depuis le début de l'année: -10.63% (699.3)
Tous les paramètres

Sous-estimation

Nom Signification Grade
P/S 1.76 8
P/BV 3.44 5
P/E 0 0
EV/EBITDA 22.91 5
Total: 5.5

Efficacité

Nom Signification Grade
ROA, % -1.13 0
ROE, % -3.26 0
Total: 0.6667

Dividendes

Nom Signification Grade
Div yield, % 0.0512 0.13
DSI 0.8571 8.57
Total: 1.79

Devoir

Nom Signification Grade
Debt/EBITDA 11.07 0
Total: 5.8

Impulsion de croissance

Nom Signification Grade
Rentabilité Revenue, % 49.63 6
Rentabilité Ebitda, % -46.65 0
Rentabilité EPS, % -289.02 0
Total: 3.2
Plus de détails

Superviseur Titre d'emploi Paiement Année de naissance
Mr. Arun Kumar Pillai B.Com. Founder & Executive Chairperson 60M 1961 (64 année)
Mr. Badree Komandur MD & Group CEO 44M 1972 (53 année)
Ms. Manjula Ramamurthy Compliance Officer & Company Secretary N/A
Sormistha Ghosh Group General Counsel, Chief Risk Officer & Chief Sustainability Officer N/A
Mr. C. K. Sundar Executive Vice President of Operations N/A
Mr. Kevin P. Cook Senior Vice President of Strides Pharma Inc. N/A
Mr. P. V. S. Ramaraju Chief Operating Officer N/A
Mr. Aditya Arun Kumar Executive Director of Business Development & Director
Mr. Vikesh Kumar Group CFO & Chief Investor Relations Officer 1985 (40 années)
Ms. Surabhi Loshali Group Chief Human Resource Officer 1980 (45 années)

Adresse: India, Bengaluru, Strides House - ouvrir dans Google Maps, ouvrir les cartes Yandex
Site web: https://www.strides.com